Prevotella intermedia Test

Your gums can look fine on the surface while a bacterial imbalance is quietly damaging the bone that holds your teeth in place. Prevotella intermedia is one of the bacteria most consistently found in that imbalance, and measuring it in your saliva or plaque gives you a direct read on whether your mouth is moving toward gum disease or away from it.

This is a salivary or subgingival test, meaning the sample comes from your spit or from the pocket of gum tissue around a tooth. It is most useful if you have been told you have gingivitis or periodontitis, if you have dental implants, or if you want a quantitative way to track your oral health beyond a dental probe and a visual exam.

What This Bacterium Actually Is

Prevotella intermedia (often abbreviated P. intermedia or Pi) is an anaerobic bacterium, meaning it thrives in low-oxygen environments like the pocket between your gum and your tooth. It is a normal resident of the mouth in small numbers, but its abundance climbs when the oral environment becomes imbalanced. Researchers call this imbalanced state oral dysbiosis.

The organism has features that help it cause damage. It can bind to and break down a class of immune proteins called IgG antibodies, which weakens your gums' local immune defense. It clusters in subgingival biofilms (the sticky bacterial mats that form below the gumline) alongside other periodontal pathogens such as Porphyromonas gingivalis and Treponema denticola, and the combination is more destructive than any single species acting alone.

Why Levels Matter for Gum Disease

Across populations, P. intermedia is found more often and at higher counts in active or severe periodontitis sites compared with healthy or inactive sites. Co-infection with Treponema denticola and P. intermedia markedly increases the odds of severe periodontitis in adult populations.

In pregnancy, levels rise alongside hormonal changes, and pregnant women show high levels of P. intermedia in the plaque under their gumline along with greater susceptibility to gingivitis. A longitudinal study tracking children from prepuberty through puberty also found that gingivitis and P. intermedia levels rose together as sex hormones increased, except in gingivitis-free males.

Dental Implants and Peri-Implant Disease

If you have implants, this organism deserves attention. A systematic review found that P. intermedia is associated with peri-implantitis, the inflammatory destruction of bone around dental implants. Sequencing studies of subgingival microbiomes show it is enriched around ailing implants compared with healthy ones, and increased microbial diversity around the implant marks the transition from healthy to diseased.

What this means for you: if you have implants and you see this organism rising on repeat tests, take it as an early warning to address oral hygiene and see your dentist before bone loss begins.

Cancer Associations

The evidence here is observational, not proof of causation, but it is worth knowing. A patient-control study found P. intermedia in 83% of oropharyngeal cancer tissue samples versus 25% of controls, with higher bacterial loads in cancer cases, though multivariable analyses attenuated the link.

In a prospective cohort of 693 mostly low-income and African American adults, people whose mouth rinse samples contained P. intermedia before any diagnosis had about 55% higher odds of developing colorectal cancer (odds ratio roughly 1.55) than non-carriers. This finding held in both African-American and European-American participants. A separate large microbiome analysis of colorectal cancer found that P. intermedia remained consistently associated with the disease even after controlling for major confounders, marking it as a candidate biomarker worth tracking.

Reconciling the Cancer Findings

Seeing P. intermedia is not a cancer diagnosis. The bacterium does not cause cancer in any straightforward way. The most plausible interpretation is that high oral levels of this organism mark a state of chronic oral and systemic inflammation, and that inflammatory state is what links to higher cancer risk over years. Acting on a high level means addressing the inflammation, not panicking about the number itself.

Brain and Mental Health Signals

A large national survey found that antibodies to P. intermedia, combined with other periodontal bacteria, were part of a composite associated with higher Alzheimer's disease mortality, particularly in older adults. A separate study of subgingival microbiomes found a distinct bacterial signature in periodontitis patients who also had Alzheimer's disease compared with cognitively unimpaired periodontitis patients.

In gut microbiome studies, P. intermedia is relatively more abundant in major depressive disorder than in bipolar depression, though this finding describes group differences and cannot be used to diagnose either condition. Treat these signals as another reason to keep oral inflammation under control, not as evidence that this bacterium causes brain disease.

Reference Ranges and Cutpoints

This is a research and emerging-clinical biomarker, not a fully standardized lab test. No professional guideline body has set universal cutoffs, and different labs use different methods (PCR copy counts, sequencing-based relative abundance, in situ hybridization), which produce different numbers. The range below comes from a salivary study of 150 adults and is illustrative orientation, not a universal target. Your lab may report different units.

Source: Saygun et al., 2011, salivary copy-counts in 150 adults. Compare your results within the same lab over time for the most meaningful trend, because assay differences between labs can shift the absolute number even when your biology has not changed.

Diagnostic Performance Compared to Other Tests

For diagnosing periodontitis, salivary P. intermedia testing performs well but is not the single best marker. A systematic review and meta-analysis of microbiome-derived biomarkers reported that in saliva, sensitivity reaches about 86.5% and specificity about 83.8% (area under the curve roughly 0.85). In subgingival plaque, sensitivity reaches up to 72% and specificity 80%. Porphyromonas gingivalis often shows comparable or slightly higher diagnostic accuracy, which is why these organisms are typically tested together rather than in isolation.

What this means for you: a single bacterial test gives you part of the picture. Pairing P. intermedia with other periodontal pathogens and with host inflammation markers (like salivary IL-6 or MMP-8) yields a sharper read on disease activity than any one number alone.

Tracking Your Trend

A single reading is a snapshot. P. intermedia levels shift with hormones, oral hygiene, treatment, and the changing makeup of the biofilm around your teeth. The trajectory matters more than any one count. Get a baseline. If you are actively addressing oral inflammation (deep cleaning, better hygiene, smoking cessation), retest in 3 to 6 months. After that, at least annual testing is reasonable for anyone who has had periodontitis, has implants, or wants serial data on oral health.

After non-surgical periodontal therapy, P. intermedia counts drop substantially, but they rarely reach zero. A drop in your number after treatment is the goal. A rise on a follow-up test is a signal to escalate, not wait.

When Results Can Be Misleading

A few factors can distort a single reading:

• Recent dental cleaning or brushing: mechanical disruption of plaque immediately before sampling can artificially lower counts. Sample before your next professional cleaning, not right after.
• Hormonal phase: levels rise during puberty and pregnancy in response to sex hormones. A high reading in these contexts may reflect a temporary, hormone-driven shift rather than fixed disease.
• Sampling site variability: subgingival samples from one tooth can differ from another. If your test pools from multiple sites or uses saliva, expect more stability between repeat tests.
• Assay differences between labs: PCR, sequencing, and culture methods produce different absolute numbers. Compare within the same lab and method over time.
• Recent systemic antibiotics: amoxicillin, metronidazole, azithromycin, or doxycycline can suppress P. intermedia for weeks after a course, producing an artificially low reading.

What to Do If Your Level Is High

A high result is a call to action, not a diagnosis. The decision pathway looks like this: pair the bacterial result with a clinical periodontal exam (probing depths, bleeding on probing, attachment levels). If you have measurable pocket depths or bleeding, see a periodontist for staging and treatment planning. If your exam looks clean, treat the high bacterial count as an early signal and tighten your home care while you wait to retest in a few months. If you have implants, request a peri-implant exam specifically, because peri-implantitis can progress quietly.

Consider ordering this test alongside other periodontal pathogens (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola) and salivary inflammation markers. A multi-organism panel gives you a more complete map of what is happening in your mouth than any single bacterial count.